Cargando…
B-Raf and the inhibitors: from bench to bedside
The B-Raf protein is a key signaling molecule in the mitogen activated protein kinase (MAPK) signaling pathway and has been implicated in the pathogenesis of a variety of cancers. An important V600E mutation has been identified and can cause constitutive B-Raf activation. Recent studies have evaluat...
Autores principales: | Huang, Tiangui, Karsy, Michael, Zhuge, Jian, Zhong, Minghao, Liu, Delong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646677/ https://www.ncbi.nlm.nih.gov/pubmed/23617957 http://dx.doi.org/10.1186/1756-8722-6-30 |
Ejemplares similares
-
MEK and the inhibitors: from bench to bedside
por: Akinleye, Akintunde, et al.
Publicado: (2013) -
Bruton tyrosine kinase inhibitor ONO/GS-4059: from bench to bedside
por: Wu, Jingjing, et al.
Publicado: (2016) -
RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021) -
B7x—from bench to bedside
por: Kaur, Gurbakhash, et al.
Publicado: (2019) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)